This study was performed to investigate the clinical features of congenital adrenal hyperplasia (CAH) with steroid 21-hydroxylase deficiency and to compare the salt-wasting (SW) type with the simple virilizing (SV) type. Twenty-seven patients (15 boys, 12 girls) who received a diagnosis of CAH at Chonnam University Hospital from May 1998 to May 2008 were enrolled in the present study. The patients' medical records were analyzed retrospectively. Age and clinical symptoms at diagnosis, ratio of bone age to chronologic age, body mass index (BMI), and treatment dose of hydrocortisone were reviewed. Of the 27 patients, 16 patients had SW type and 11 patients had SV type. The SV patients were significantly older (p＜0.05) at the time of diagnosis (45.1±40.4 months) than were the SW patients (1.8±4.4 months). In the SW patients, the initial ratio of bone age to chronologic age was 1.10±0.15 in the boys and 1.52±0.74 in the girls, and the final BMI was 16.6±2.81 kg/m 2 in the boys and 17.4±4.21 kg/m 2 in the girls. In the SV patients, the initial ratio of bone age to chronologic age was 1.26±0.38 in the boys and 1.45±0.31 in the girls, and the final BMI was 17.5±2.62 kg/m 2 in the boys and 19.6±1.80 kg/m 2 in the girls. The treatment dose of hydrocortisone was 18.4±6.54 mg/m 2 /day in the SW patients and 16.1±5.50 mg/m 2 /day in the SV patients. The ratio of bone age to chronological age, BMI, and dose of hydrocortisone were not significantly different between the SV and SW patients. 서 론 선천 부신 과다형성(congenital adrenal hyperplasia, CAH) 은 부신 피질에서 코티솔이 형성되는 과정에 장애가 생겨 발생하는 질환군으로서, 95% 이상에서 cytochrome P450 계 효소인 스테로이드 21-수산화효소(hydroxylase)의 기능 이 없어서 생기는 것으로 알려져 있다. 1 21-수산화효소의 결 핍은 부신에서 생성되는 코티솔과 알도스테론의 생성을 저 하시키고, 이차적으로 부신피질자극호르몬(adrenocorticotropic hormone, ACTH)의 과분비로 인하여 부신피질이 과형성되며 부신에서 안드로겐의 생성을 촉진시켜 남성화를 진행시킨다. 1 CAH는 상염색체 열성으로 유전되는 질환으 로 질병의 빈도는 전 세계적으로 시행한 신생아 집단선별검
. Changes of ratio of bone age to chronologic age and body mass index 
Salt wasting Simple virilizing
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ Male Female Male
